Could a cocktail of Non-Opioid drugs replace Morphine-Like painkillers in the ICU?

NCT ID NCT05825560

First seen Jul 01, 2026 · Last updated Jul 01, 2026

Summary

This trial investigates whether a combination of non-opioid pain medications (paracetamol, nefopam, tramadol, and ketamine) can effectively manage pain in intensive care unit patients who need a breathing machine, while reducing the use of the opioid remifentanil. The study involves 50 adults in the ICU who have been on a ventilator for 2 to 24 hours. Half receive the standard opioid-based pain regimen, and the other half receive the opioid-free mix, with neither patients nor doctors knowing which group they are in. The main goal is to see if the opioid-free approach cuts remifentanil use by at least 15% in the first 48 hours.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

Multimodal opioid-free analgesia (paracetamol, nefopam, tramadol, ketamine)

What this could lead to

If successful, this approach could reduce reliance on opioids for ICU patients, lowering risks like addiction and breathing problems.

What could go wrong

This is a small, early feasibility study with only 50 participants, so results may not apply broadly. The drug combination may not work as well as opioids for pain control.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for INTUBATION are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Remy WIDEHEM

    Nîmes, Gard, 30029, France